Donor-Derived Second Generation of CD19 CAR-T Cell Therapy for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogenic Stem Cell Transplantation

被引：7
|
作者：
Zhang, Rongli [1 ,2 ,3 ]
He, Yi [1 ,2 ,3 ]
Yang, Donglin [1 ,2 ,3 ]
Wang, Ying [2 ,4 ]
Feng, Sizhou [1 ,2 ,3 ]
Wang, Jianxiang [2 ,5 ]
Han, Ming-Zhe [1 ,2 ,3 ]
机构：
[1] CAMS, Stem Cell Transplantat Ctr, Inst Hematol, Tianjin, Peoples R China
[2] CAMS, Hosp Blood Dis, Tianjin, Peoples R China
[3] PUMC, Tianjin, Peoples R China
[4] Chinese Acad Med Sci, Leukemia Ctr, Inst Hematol, Tianjin, Peoples R China
[5] Chinese Acad Med Sci, State Key Lab Expt Hematol, Inst Hematol, Tianjin, Peoples R China
来源：
BLOOD | 2018年 / 132卷
关键词：
donor-derived CD19 CAR-T cell therapy; allogenic stem cell transplantation; B cell acute lymphoblastic leukemia; relapse;
D O I：
10.1182/blood-2018-99-114950
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2179
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] Allogeneic donor-derived CD19 CAR-T therapy of relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
    马润芝
    China Medical Abstracts (Internal Medicine), 2021, (04) : 228 - 229
  • [2] Long-Term Outcomes Following Donor-Derived Anti-CD19 CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia Patients Relapsed after Allogenic Stem Cell Transplantation
    Zhang, Rongli
    Wang, Ying
    Zou, Dehui
    Jiang, Erlie
    He, Yi
    Yang, Donglin
    Feng, Sizhou
    Wang, Jianxiang
    Han, Ming-Zhe
    BLOOD, 2020, 136
  • [3] Combination of CD19 and CD22 CAR-T cell therapy in relapsed B-cell acute lymphoblastic leukemia after allogeneic transplantation
    Liu, Shuangyou
    Deng, Biping
    Yin, Zhichao
    Lin, Yuehui
    An, Lihong
    Liu, Dan
    Pan, Jing
    Yu, Xinjian
    Chen, Bingzhen
    Wu, Tong
    Chang, Alex H.
    Tong, Chunrong
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (06) : 671 - 679
  • [4] Donor-derived stem cell infusion for sustained pancytopenia after CD19 CAR-T therapy for relapsed patients post allogeneic stem cell transplantation
    Li, Yingying
    Li, Yixue
    Zhang, Mingming
    Zhao, Houli
    Zhu, Miaoyong
    Huang, He
    Hu, Yongxian
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (01) : 94 - 101
  • [5] Efficacy and safety of CD19 CAR-T cell therapy for acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation
    Cao, Xing-Yu
    Li, Jing-Jing
    Lu, Pei-Hua
    Liu, Kai-Yan
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (03) : 315 - 329
  • [6] Efficacy and safety of CD19 CAR-T cell therapy for acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation
    Xing-yu Cao
    Jing-jing Li
    Pei-hua Lu
    Kai-yan Liu
    International Journal of Hematology, 2022, 116 : 315 - 329
  • [7] Success of donor-derived CAR-T cells after failure of autologous CD19 CAR-T cells (tisagenlecleucel) in B-cell acute lymphoblastic leukaemia
    Dourthe, Marie Emilie
    Yakouben, Karima
    David, Audrey
    Thouvenin, Sandrine
    Chaillou, Delphine
    Caillat-Zucman, Sophie
    Cuffel, Alexis
    Tardy, Clea
    Lainey, Elodie
    Caye-Eude, Aurelie
    Arfeuille, Chloe
    Delaugerre, Constance
    Chaix-Baudier, Marie-Laure
    Naudin, Jerome
    Auvin, Stephane
    Bergaoui, Karim
    Merlat-Guitard, Anne-Isabelle
    De Jorna, Romain
    Mebarki, Miryam
    Dalle, Jean-Hugues
    Baruchel, Andre
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (01) : 373 - 377
  • [8] CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia
    Testa, Ugo
    Sica, Simona
    Pelosi, Elvira
    Castelli, Germana
    Leone, Giuseppe
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [9] CAR-T cells and allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia
    Liu, Jun
    Zhang, Xi
    Zhong, Jiang F.
    Zhang, Cheng
    IMMUNOTHERAPY, 2017, 9 (13) : 1115 - 1125
  • [10] CD22 Gating for Flow Cytometric Analysis in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia after CD19 CAR-T Therapy
    Yu, Xinjian
    Li, Pan
    Feng, Heyuan
    Kang, Jian
    Zheng, Xichang
    Zhang, Yunmei
    Yang, Wenhong
    Wu, Tong
    Liu, Shuangyou
    BLOOD, 2020, 136
12345